Lexington, MA, United States of America

Fuji Immunopharmaceuticals Corp.


USPTO Granted Patents = 6

Forward Citations = 412

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal Stephen D Gillies (4 out of 74 patents)

silverMedal Kin-Ming Lo (3 out of 40 patents)

bronzeMedal Mitsunori Ono (2 out of 94 patents)

4.  Hiroshi Kitaguchi (2 out of 36 patents)

5.  Yukio Sudo (2 out of 2 patents)

6.  Hideto Mori (1 out of 37 patents)

7.  Yumiko Wada (1 out of 25 patents)

8.  Naoyuki Nishikawa (1 out of 50 patents)

9.  Yaming Wu (1 out of 16 patents)

10.  Tomohiro Ogawa (1 out of 4 patents)

11.  Ryoichi Nemori (1 out of 12 patents)

12.  Hideaki Satoh (1 out of 9 patents)

13.  Shigeru Yamazaki (1 out of 9 patents)

14.  Yumiko Jimbo (1 out of 1 patent)

15.  Hiroshi Kataguchi (1 out of 1 patent)


6 patents:

Company Overview
Fuji Immunopharmaceuticals Corp. is a biotechnology company specializing in the development of innovative immunotherapies for various diseases. With a focus on harnessing the power of the immune system, the company's research and development efforts aim to address unmet medical needs. Fuji Immunopharmaceuticals is committed to advancing the field of immunotherapy through cutting-edge science and a dedication to improving patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#86 in Lexington, MA

#2,545 in Massachusetts

#44,981 in US

Lexington, MA (US)
Lexington, MA, United States of America
Forward Citations = 412

20 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fuji Immunopharmaceuticals Corp.. Retrieved from https://idiyas.com/company/fuji-immunopharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…